STAPLOE MEDICAL CENTRE — All Prescriptions & Medications — Page 14
Practice Code: D81014 | ELY, CB7 5JD
Showing results 651-700 of 706
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Temazepam | 13 | 314 | £253 | -77.3% ▼ |
| Dosulepin hydrochloride | 13 | 728 | £173 | -77.0% ▼ |
| Perampanel | 13 | 364 | £1.7K | -40.0% ▼ |
| Oxcarbazepine | 13 | 2,184 | £359 | -53.5% ▼ |
| Doxycycline monohydrate | 13 | 306 | £173 | +19.7% ▲ |
| Ins degludec/liraglutide | 13 | 63 | £2.0K | -19.1% ▼ |
| Drospirenone | 13 | 1,848 | £301 | +102.0% ▲ |
| Magnesium lactate | 13 | 980 | £206 | +88.6% ▲ |
| Ascorbic acid | 13 | 364 | £608 | -36.7% ▼ |
| Powder delisted probiotic (0913531) | 13 | 390 | £437 | +90.3% ▲ |
| Valsartan with diuretic | 12 | 336 | £182 | -9.4% ▼ |
| Flupentixol hydrochloride | 12 | 720 | £33 | -63.4% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 12 | 750 | £975 | +8.7% ▲ |
| Primidone | 12 | 720 | £628 | -66.3% ▼ |
| Colistimethate sodium | 12 | 620 | £3.7K | +6.1% ▲ |
| Vitamins caps | 12 | 336 | £7 | -78.2% ▼ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 12 | 246 | £681 | +20.8% ▲ |
| Specialist food replacer pasta (0913261) | 12 | 12.0K | £195 | -18.5% ▼ |
| Tube feed 1 kcal/ml peptide based (0914041) | 12 | 273.0K | £5.2K | +35.0% ▲ |
| Fluorometholone | 12 | 105 | £31 | -16.7% ▼ |
| Dexpanthenol | 12 | 430 | £39 | +129.4% ▲ |
| 12 | 270 | £955 | -27.9% ▼ | |
| 12 | 12 | £48 | +411.0% ▲ | |
| 12 | 1,700 | £349 | +64.2% ▲ | |
| Fluvastatin sodium | 11 | 308 | £43 | -52.4% ▼ |
| Phenelzine sulfate | 11 | 1,232 | £1.5K | +7.4% ▲ |
| Modafinil | 11 | 750 | £177 | -47.2% ▼ |
| Paracetamol combined preparations | 11 | 2,198 | £429 | +45.5% ▲ |
| Cefradine | 11 | 308 | £177 | +16.2% ▲ |
| Cyproterone acetate | 11 | 33 | £39 | +0.2% vs avg |
| Specialist food replacer flour type mixes (0913261) | 11 | 7,600 | £115 | +40.0% ▲ |
| Tube feed 0.75 kcal/ml with fibre (0914021) | 11 | 308.0K | £6.3K | +10.7% ▲ |
| Tube feed 1.2 kcal/ml peptide based | 11 | 198.0K | £3.3K | +48.9% ▲ |
| Atropine sulfate | 11 | 140 | £1.5K | -13.7% ▼ |
| 11 | 176 | £32 | -40.0% ▼ | |
| 11 | 455 | £232 | -70.4% ▼ | |
| 11 | 11 | £440 | +173.1% ▲ | |
| 11 | 1,128 | £2.3K | -48.0% ▼ | |
| 11 | 683 | £497 | -67.0% ▼ | |
| 11 | 840 | £2.8K | -0.3% vs avg | |
| 11 | 330 | £1.2K | -16.9% ▼ | |
| Phosphates (Rectal) | 10 | 97 | £1.3K | -18.2% ▼ |
| Paliperidone | 10 | 10 | £6.1K | -34.2% ▼ |
| Levodopa/carbidopa/entacapone | 10 | 1,140 | £752 | -64.2% ▼ |
| Insulin glulisine | 10 | 40 | £640 | -53.4% ▼ |
| Dienogest | 10 | 336 | £230 | +38.1% ▲ |
| 10 | 201.6K | £3.3K | +10.3% ▲ | |
| Ketorolac trometamol | 10 | 50 | £36 | +7.8% ▲ |
| Hydrocortisone | 10 | 100 | £69 | +285.1% ▲ |
| Other barrier preparations | 10 | 420 | £45 | +69.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.